Treatment of pluripotent cells
US8623648B2 · kind B2 · utility
2Cited by
61References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 24, 2008 |
| Grant date | Jan 7, 2014 |
| Priority date | — |
| Expiry date | Mar 6, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2506/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to methods to treat pluripotent cells, whereby the pluripotent cells can be efficiently expanded in culture and differentiated by treating the pluripotent cells with an inhibitor of GSK-3B enzyme activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.